Prospective Collection of Samples to Enable the Validation of Circulating DNA Biomarkers for the Early Detection of Ovarian Cancer


recruiting iconRECRUITING


Prospective collection of pre-operative blood samples and serial post-operative blood samples, and matched FFPE ovarian tissue samples (either malignant or benign) from women known to be suffering from HBOC Syndrome who undergo an elective RRBSO or RRSO to be used in the prospective validation of novel, non-invasive blood-based ovarian cancer screening tests assaying ctDNA (HBOC Surgery Group).


James Ford, MD